Assessment of cholestasis in drug-induced liver injury by different methods
Authors:
Open Access
- 1 February 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (6) , e14399
Abstract
Cholestasis in drug-induced liver injury (DILI) can be assessed by biochemical and pathologic methods, but the agreement between the 2 methods remains unclear. The aim of this study was to identify the accurate method for assessment of cholestasis in DILI. The DILI standard established and revised by the Council for International Organizations of Medical Sciences (CIOMS) (R values were calculated by liver function at different time points), cholestatic liver disease guideline (European Association for the Study of the Liver, EASL), and liver pathology were used to assess, compare, and analyze the cholestasis in 133 patients with DILI. The R values at different time points in CIOMS standard had no statistical difference for the assessment of cholestatic DILI (a = 0.05, χ2 = 1.51, P = .679). There were statistical differences among the results of CIOMS, EASL, and pathology (a = 0.05, χ2 = 99.97, P < .001). EASL standard had no statistical difference with pathology (a = 0.003, χ2 = 8.00, P = .005). CIOMS and EASL standards based on biochemical parameters underestimated cholestatic DILI, as compared to liver pathology.Keywords
This publication has 14 references indexed in Scilit:
- Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver InjuryGastroenterology, 2014
- Slow but Steady Progress in a Field with Many Knowledge GapsSeminars in Liver Disease, 2014
- Drug-Induced Liver InjuryMayo Clinic Proceedings, 2014
- An Update on Drug-induced Liver InjuryJournal of Clinical and Experimental Hepatology, 2012
- Standardization of nomenclature and causality assessment in drug‐induced liver injuryHepatology, 2010
- Valproic Acid-Associated Vanishing Bile Duct SyndromeJournal of Child Neurology, 2010
- Diagnosis, management and prevention of drug-induced liver injuryGut, 2009
- EASL Clinical Practice Guidelines: Management of cholestatic liver diseasesJournal of Hepatology, 2009
- Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registryHepatology, 2006
- Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuriesJournal of Clinical Epidemiology, 1993